TrialArthritis & rheumatology (Hoboken, N.J.)2025

Efficacy of a Tumor Necrosis Factor Inhibitor in Chronic Low-Back Pain With Modic Type 1 Changes: A Randomized Controlled Trial.

Elisabeth Gjefsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.